HEMISPHERX BIOPHARMA INC (HEB) has 66 open-market insider trades by 16 insiders since 2006. The most active filer is Thomas K. Equels, CEO & Chairman +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| William A. Carter | CEO10% | — | 11 | $1.1M | 2015-08-20 |
| Thomas K. Equels | CEOChairmanPres | — | 22 | $711K | 2019-06-27 |
| David R. Strayer | Chief Science/Medical Officer | — | 8 | $211K | 2019-06-21 |
| Wayne S. Springate | Sr VP of Operations | — | 4 | $173K | 2017-05-02 |
| Charles Thomas Bernhardt III | CFO | — | 2 | $170K | 2010-06-15 |
| Stewart Appelrouth | Dir | — | 5 | $150K | 2019-08-16 |
| Steven D. Spence | Dir | — | 1 | $103K | 2007-04-04 |
| Richard Piani | Dir | — | 1 | $59K | 2009-06-09 |
| William M. Mitchell | Dir | — | 1 | $39K | 2019-08-16 |
| Peter W. Rodino III | Dir Govt Relations/Sectry | — | 1 | $35K | 2019-06-21 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Thomas K. Equels | Chairman | Buy | $12K | 2019-06-27 |
| Wayne S. Springate | Sr. VP of Operations | Buy | $21K | 2019-06-21 |
| William M. Mitchell | Director | Buy | $39K | 2019-06-21 |
| Thomas K. Equels | CEO & Chairman +1 | Buy | $237K | 2019-06-21 |
| David R. Strayer | Chief Science/Medical Officer | Buy | $10K | 2019-06-21 |
| Peter W. Rodino III | Dir Govt Relations/Sectry | Buy | $35K |
Companies that share insiders with HEB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2019-06-21 |
| Thomas K. Equels | Chairman | Buy | $2K | 2019-03-19 |
| Thomas K. Equels | Chairman | Buy | $4K | 2018-11-30 |
| Stewart Appelrouth | Director | Buy | $6K | 2018-11-05 |
| Thomas K. Equels | Chairman | Buy | $700 | 2018-10-26 |
| Thomas K. Equels | Chairman | Buy | $20K | 2018-10-25 |
| Thomas K. Equels | Chairman | Buy | $10K | 2018-07-27 |
| Stewart Appelrouth | Director | Buy | $39K | 2018-07-24 |
| Wayne S. Springate | Sr. VP of Operations | Buy | $10K | 2018-07-23 |
| Thomas K. Equels | Chairman | Buy | $35K | 2018-07-23 |